Pharma

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Most Viewed Abstracts



Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

GW Pharmaceuticals has filed for approval of its cannabis-based drug for multipl sclerosis, Sativex in Spain and the UK. If the drug, currently available in Canada, is approved, regulators would allow the drug to be marketed across Europe for all patients with spasticity, the involuntary spasms associated with MS.

Today in Regulatory Issues...keeping you current

Two Delivery Systems Win Baldrige Award
HealthDataManagement, 12/17/09

Advisory Committee briefing materials for CRESTOR sNDA available on US FDA web site
AstraZeneca, 12/15/09

Sixteen Fired for Records Snooping
HealthDataManagement, 12/09/09

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address